{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T10:41:02Z","timestamp":1774953662511,"version":"3.50.1"},"reference-count":21,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2009,8,1]],"date-time":"2009-08-01T00:00:00Z","timestamp":1249084800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2009,8,1]],"date-time":"2009-08-01T00:00:00Z","timestamp":1249084800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2017,12,4]],"date-time":"2017-12-04T00:00:00Z","timestamp":1512345600000},"content-version":"vor","delay-in-days":3047,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"name":"Department of Health Pharmacogenetics research programme"}],"content-domain":{"domain":["bjanaesthesia.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["British Journal of Anaesthesia"],"published-print":{"date-parts":[[2009,8]]},"DOI":"10.1093\/bja\/aep108","type":"journal-article","created":{"date-parts":[[2009,5,19]],"date-time":"2009-05-19T22:41:01Z","timestamp":1242772861000},"page":"220-225","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"title":["Epigenetic allele silencing and variable penetrance of malignant hyperthermia susceptibility"],"prefix":"10.1016","volume":"103","author":[{"given":"R.L.","family":"Robinson","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Carpenter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.J.","family":"Halsall","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.E.","family":"Iles","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Booms","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Steele","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.M.","family":"Hopkins","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.-A.","family":"Shaw","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1093\/bja\/aep108_bib1","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1093\/bja\/83.2.217","article-title":"Segregation of malignant hyperthermia, central core disease and chromosome 19 markers","volume":"83","author":"Curran","year":"1999","journal-title":"Br J Anaesth"},{"key":"10.1093\/bja\/aep108_bib2","doi-asserted-by":"crossref","first-page":"2581","DOI":"10.1093\/hmg\/10.22.2581","article-title":"Familial and sporadic forms of central core disease are associated with mutations in the C terminal domain of the skeletal muscle ryanodine receptor","volume":"22","author":"Monnier","year":"2001","journal-title":"Hum Mol Genet"},{"key":"10.1093\/bja\/aep108_bib3","doi-asserted-by":"crossref","first-page":"e33","DOI":"10.1136\/jmg.2003.014274","article-title":"Robinson R. RYR1 mutations in UK central core disease patients: more than just the C-terminal transmembrane region of the RYR1 gene","volume":"41","author":"Shepherd","year":"2004","journal-title":"J Med Genet"},{"key":"10.1093\/bja\/aep108_bib4","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1002\/humu.20356","article-title":"Mutations in RYR1 in malignant hyperthermia and central core disease","volume":"27","author":"Robinson","year":"2006","journal-title":"Hum Mutat"},{"key":"10.1093\/bja\/aep108_bib5","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1002\/ana.10231","article-title":"A recessive form of central core disease, transiently presenting as multiminicore disease, is associated with a homozygous mutation in the ryanodine receptor type 1 gene","volume":"51","author":"Ferreiro","year":"2002","journal-title":"Ann Neurol"},{"key":"10.1093\/bja\/aep108_bib6","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1212\/WNL.59.2.284","article-title":"Autosomal recessive inheritance of RYR1 mutations in congenital myopathy with cores","volume":"59","author":"Jungbluth","year":"2002","journal-title":"Neurology"},{"key":"10.1093\/bja\/aep108_bib7","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1001\/archneur.61.1.106","article-title":"Multiminicore disease in a family susceptible to malignant hyperthermia: histology, in vitro contracture tests, and genetic characterisation","volume":"61","author":"Guis","year":"2004","journal-title":"Arch Neurol"},{"key":"10.1093\/bja\/aep108_bib8","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1086\/508500","article-title":"Epigenetic allele silencing unveils recessive RYR1 mutations in core myopathies","volume":"79","author":"Zhou","year":"2006","journal-title":"Am J Hum Genet"},{"key":"10.1093\/bja\/aep108_bib9","doi-asserted-by":"crossref","first-page":"2791","DOI":"10.1093\/hmg\/ddl221","article-title":"Characterization of recessive RYR1 mutations in core myopathies","volume":"15","author":"Zhou","year":"2006","journal-title":"Hum Mol Genet"},{"key":"10.1093\/bja\/aep108_bib10","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1038\/343559a0","article-title":"Ryanodine receptor gene is a candidate for predisposition to malignant hyperthermia","volume":"343","author":"MacLennan","year":"1990","journal-title":"Nature"},{"key":"10.1093\/bja\/aep108_bib11","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1093\/bja\/86.2.283","article-title":"Guidelines for molecular detection of susceptibility to MH","volume":"86","author":"Urwyler","year":"2001","journal-title":"Br J Anaesth"},{"key":"10.1093\/bja\/aep108_bib12","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1038\/sj.ejhg.5200964","article-title":"Recent advance in the diagnosis of malignant hyperthermia susceptibility: how confident can we be of genetic testing?","volume":"11","author":"Robinson","year":"2003","journal-title":"Eur J Hum Genet"},{"key":"10.1093\/bja\/aep108_bib13","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1046\/j.1469-1809.2000.6440307.x","article-title":"Multiple interacting gene products may influence susceptibility to malignant hyperthermia","volume":"64","author":"Robinson","year":"2000","journal-title":"Ann Hum Genet"},{"key":"10.1093\/bja\/aep108_bib14","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/j.tig.2005.06.008","article-title":"A census of mammalian imprinting","volume":"21","author":"Morison","year":"2005","journal-title":"Trends Genet"},{"key":"10.1093\/bja\/aep108_bib15","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1038\/ng0297-181","article-title":"Human KVLQT gene shows tissue-specific imprinting and encompasses Beckwith\u2013Wiedemann syndrome chromosomal rearrangements","volume":"15","author":"Lee","year":"1997","journal-title":"Nat Genet"},{"key":"10.1093\/bja\/aep108_bib16","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1111\/j.1399-6576.1997.tb04820.x","article-title":"In vitro contracture test for diagnosis of malignant hyperthermia following the protocol of the European MH Group: results of testing patients surviving fulminant MH and unrelated low-risk subjects","volume":"41","author":"\u00d8rding","year":"1997","journal-title":"Acta Anaesthesiol Scand"},{"key":"10.1093\/bja\/aep108_bib17","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1002\/humu.20231","article-title":"Correlations between genotype and pharmacological, histological, functional, and clinical phenotypes in malignant hyperthermia susceptibility","volume":"26","author":"Monnier","year":"2005","journal-title":"Hum Mutat"},{"key":"10.1093\/bja\/aep108_bib18","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1111\/j.1365-2044.1990.tb14566.x","article-title":"Clinical presentation of suspected malignant hyperthermia during anaesthesia in 402 probands","volume":"45","author":"Ellis","year":"1990","journal-title":"Anaesthesia"},{"key":"10.1093\/bja\/aep108_bib19","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1111\/j.1399-6576.2007.01293.x","article-title":"Male preponderance of patients testing positive for malignant hypethermia susceptibility","volume":"51","author":"Islander","year":"2007","journal-title":"Acta Anaesthesiol Scand"},{"key":"10.1093\/bja\/aep108_bib20","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1016\/S0960-8966(02)00002-0","article-title":"Workshop report of the 89th ENMC international workshop: central core disease, 19\u201320th January 2001, Hilversum, The Netherlands","volume":"12","author":"De Cauwer","year":"2002","journal-title":"Neuromuscul Disord"},{"key":"10.1093\/bja\/aep108_bib21","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1097\/00005792-198709000-00004","article-title":"Central core disease: clinical features in 13 patients","volume":"66","author":"Shuaib","year":"1987","journal-title":"Medicine"}],"container-title":["British Journal of Anaesthesia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0007091217340084?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0007091217340084?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/academic.oup.com\/bja\/article-pdf\/103\/2\/220\/1051898\/aep108.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,13]],"date-time":"2025-09-13T18:46:23Z","timestamp":1757789183000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0007091217340084"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,8]]},"references-count":21,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2009,8]]}},"alternative-id":["S0007091217340084"],"URL":"https:\/\/doi.org\/10.1093\/bja\/aep108","relation":{},"ISSN":["0007-0912"],"issn-type":[{"value":"0007-0912","type":"print"}],"subject":[],"published":{"date-parts":[[2009,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Epigenetic allele silencing and variable penetrance of malignant hyperthermia susceptibility","name":"articletitle","label":"Article Title"},{"value":"British Journal of Anaesthesia","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1093\/bja\/aep108","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2009 British Journal of Anaesthesia. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}